Sentence examples for using a microarray assay from inspiring English sources

(A) Initial screening of miR-139-5p miR-139-5p miR-139-5pmicroarray assay, bioinformatargetredictions and the luciferase reporter assay.

After exposure, cells were analyzed using a microarray assay to probe for all known human miRNA species identified in the Sanger miRBase (Fig. 1).

To address the question of how transplanted cells provide their beneficial effect, we investigated human Th1 and Th2 cytokines in plasma of G93A mice transplanted with different MNC hUCB cell doses using a microarray assay.

Using a microarray assay to assess expression of 66 inflammation genes in the liver of control and transgenic mice, we found that the expression of 21 inflammation genes was decreased, while the expression of other 45 inflammation genes was unchanged in C/EBPβ-Ala217 mice after CCl4 induced liver injury, when compared to C/EBPβ+/+ animals treated with CCl4 (Table 1).

The influenza A viruses were then subtyped from swabs by using a microarray assay (Clondiag, Jena, Germany) that enabled the rapid identification of influenza virus A (H10N7).

To explore whether CTN06 modulates miRNAs, 272 miRNA levels in PC3 cells were examined using a microarray assay following treatment with CTN06.

The identification of differentially expressed genes or patterns of gene expression using a microarray hybridization assay provides a logical approach to developing potential biomarkers of toxicity.

To understand the epigenetic regulation required for germ cell-specific gene expression in the mouse, we analysed DNA methylation profiles of developing germ cells using a microarray-based assay adapted for a small number of cells.

One-hundred and twenty-three breasamplesles (117 invasive carcinomas, one fibroadenoma and five normal tissues) and three breast cancer cell lines were prospectively analyzed using a microarray (Agilent) and a qRT-PCR assay comprised of 53 genes.

In this study, we demonstrate that serum miRNAs can be used to discriminate between cancer patient sera and normal donor sera, using a simple microarray assay that requires no amplification step.

Using a tissue microarray assay, we found that Btk is overexpressed in prostate cancer tissues.